ADAMTS13 and COVID-19: ADAMTS13 gene encodes for a plasma glycoprotein with protease activity that plays a fundamental role in platelet adhesion and aggregation on vascular lesions, and the reduced activity of ADAMTS13 is already reported to be associated with a severe COVID-19 outcome [7].